Europe’s medical devices industry saw a rise of 32.35% in deal activity during January 2022

Europe’s medical devices industry saw a rise of 32.35% in deal activity during January 2022, when compared with the last 12-month average, led by Ardian Holding’s $1.26bn private equity deal with Biofarma, according to GlobalData’s deals database.

A total of 45 medical devices industry deals worth $1.7bn were announced for the region in January 2022, against the 12-month average of 34 deals.

Of all the deal types, venture financing saw most activity in January 2022 with 22 transactions, representing a 48.9% share for the region.

In second place was M&A with 18 deals, followed by private equity deals with five transactions, respectively capturing a 40% and 11.1% share of the overall deal activity for the month.

In terms of value of deals, private equity was the leading category in Europe’s medical devices industry with $1.28bn, while venture financing and M&A deals totalled $433.85m and $28.45m, respectively.

Europe medical devices industry deals in January 2022: Top deals

The top five medical devices deals accounted for 87.4% of the overall value during January 2022.

The combined value of the top five medical devices deals stood at $1.52bn, against the overall value of $1.7bn recorded for the month.

The top five medical devices industry deals of January 2022 tracked by GlobalData were:

1) Ardian Holding $1.26bn private equity deal for 70% stake in Biofarma

2) The $90m venture financing of DistalMotion by 415 Capital Management and Revival Healthcare

3) ARCH Venture Partners,ARTIS Ventures,Axon Ventures,Casdin Capital,Oxford Science Enterprises,Section 32 and Vertical Venture Partners $75m venture financing deal with ONI

4) The $55m venture financing of InnovHeart by Genextra,Grand Pharmaceutical Group,Indaco Venture Partners SGR and Panakes Partners

5) Genesis MedTech International and Sofinnova Partners $44.59m venture financing deal with Safeheal